Forth, new and more sensitive PET tracers for prostate cancer, such as 18F-FACBC[17] and 68Ga-PSMA,[18] were recently introduced for clinical use in western countries, but they are not yet available in Japan. This evidence concerns the gene FOLH1 and prostate cancer.